Flash Finance

Healthcare Global Enterprises LimitedHCGCorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹588.20
MCap ₹8,782 Cr · P/E n/m
Healthcare Global Enterprises Limited — Stock analysis & AI research Healthcare Global Enterprises Limited — Multibagger AI analysis Healthcare Global Enterprises Limited — Seasonality — best & worst months Healthcare Global Enterprises Limited — Technical indicators & charts Healthcare Global Enterprises Limited — Technical setup — score, trend, support & resistance Healthcare Global Enterprises Limited — Live exchange announcements
📋 Promoters Increasing Stake 📈 RSI Oversold Stocks📈 Lowest Technical Score 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹377 Cr
Sales · Jun 2026
+15.2% YoY
₹59 Cr
Operating Profit · Jun 2026
+18.8% YoY
15.7%
OPM % · Jun 2026
+3.3% YoY
₹6 Cr
Net Profit · Jun 2026
+61.7% YoY
₹0.37
EPS · Jun 2026
+60.9% YoY

📝 Healthcare Global Enterprises Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Healthcare Global Enterprises Limited reported revenue of ₹377 crore for the quarter ended June 2026 (Q1 FY27), up 15.2% from ₹327 crore in the same quarter last year, and up 7.6% sequentially over the March 2026 quarter.

Net profit rose 61.7% year-on-year to ₹6 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹0.37.

Operating profit stood at ₹59 crore — an operating margin (OPM) of 15.7%, compared with 15.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Healthcare Global Enterprises Limited posted revenue of ₹1,364 crore, a growth of 10.4% over FY25, with a net profit of ₹15 crore (up 2457.9% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,413 crore with a net profit of ₹17 crore.

Valuation snapshot

At the current price of ₹588.20, HCG has a market capitalisation of ₹8,782 crore and a P/E that is not meaningful, because trailing profit is close to zero.

Within the Healthcare industry, it is the 3rd-largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 64.21%, foreign institutional investors (FIIs) 2.69%, domestic institutional investors (DIIs) 20.77%, public shareholders 12.32% of Healthcare Global Enterprises Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹8,782 Cr
Current Price ?
₹588.2
P/E ?
n/m
Industry P/E ?
34.70
P/B ?
5.48
P/S ?
6.21
P/FCF ?
1,097.74
Enterprise Value ?
₹9,804 Cr
EV/EBITDA ?
39.29
PEG ?
n/m
Earnings Yield ?
1.2%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹1,413 Cr
OPM ?
17.7%
Profit after tax (TTM) ?
₹17 Cr
EPS (TTM) ?
₹1.12
ROCE ?
6.0%
ROE ?
1.0%
ROA ?
0.6%
Growth
Sales — latest qtr ?
₹377 Cr
PAT — latest qtr ?
₹6 Cr
YoY qtr sales growth ?
15.2%
YoY qtr profit growth ?
61.7%
Sales growth (3y) ?
11%
Sales growth (5y) ?
18%
Profit growth (3y) ?
15%
Profit growth (5y) ?
30%
Financial Health
Debt ?
₹1,022 Cr
Debt to Equity ?
0.64
Interest Coverage ?
1.4
Current Ratio ?
N/A
Ownership
Promoter holding ?
64.21%
Change in promoter holding ?
1.75%
Pledged percentage ?
N/A
Market
Return 3 months ?
-10.3%
Return 6 months ?
4.0%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 258272282266279293306312324327344342350377 +15.2% +7.6%
Operating Profit 4047504654495741595061547559 +18.8% -21.2%
Other Income 4336511116985-5-3310 +20.4% +129.3%
Interest 1010111314192021222421212022 -10.6% +7.6%
Depreciation 2322232425262728292830303140 +40.1% +26.4%
Profit Before Tax 818181541521-3617515-1-97 +42.7% +183.6%
Net Profit 414148-21216-3710311-126 +61.7% +264.7%
EPS 0.300.980.980.60-0.130.841.15-2.680.690.230.77-0.080.100.37 +60.9% +270.0%
OPM % 15.3% 17.2% 17.6% 17.3% 19.2% 16.8% 18.7% 13.3% 18.2% 15.2% 17.7% 15.9% 21.5% 15.7% +3.3% -27.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,235 Cr ₹1,364 Cr ₹1,413 Cr +10.4%
Operating Profit ₹207 Cr ₹240 Cr ₹250 Cr +16.1%
OPM % 16.76% 17.61% 17.65% +5.1%
NPM % 0.05% 1.07% 1.18% +2040.0%
Other Income ₹38 Cr ₹-24 Cr ₹-23 Cr -164.4%
Depreciation ₹110 Cr ₹120 Cr ₹131 Cr +9.0%
Interest ₹83 Cr ₹86 Cr ₹84 Cr +3.8%
EBIT ₹97 Cr ₹120 Cr ₹118 Cr +24.1%
PBT ₹17 Cr ₹10 Cr ₹12 Cr -42.1%
Tax ₹9 Cr ₹4 Cr ₹6 Cr -59.4%
Net Profit ₹1 Cr ₹15 Cr ₹17 Cr +2457.9%
EPS ₹-0.00 ₹1.02 ₹1.16 +306244774661193856.0%
Material Cost ₹223 Cr ₹91 Cr ₹186 Cr -59.3%
Employee Cost ₹164 Cr ₹53 Cr ₹113 Cr -67.8%
Extraordinary Items ₹-35 Cr — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Borrowings 3477581,1181,022 -8.6%
Equity Capital 139139139149 +7.2%
Reserves 1,0061,0421,0521,455 +38.3%
Other Liabilities 237299295291 -1.4%
Total Liabilities 1,7302,2392,6042,917 +12.0%
Fixed Assets 7889741,0381,122 +8.1%
CWIP 9362314 -39.1%
Investments 475506696704 +1.1%
Other Assets 4587228471,078 +27.3%
Total Assets 1,7302,2392,6042,917 +12.0%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 130209146160 +9.6%
Cash from Investing Activity -138-254-347-76 +78.1%
Cash from Financing Activity -4296-42336 +900.0%
Net Cash Flow -4951-243421 +273.3%
Free Cash Flow 3680138 -38.5%
CFO/OP 81%121%78%70% -10.3%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 77697570 -6.7%
Inventory Days 33302326 +13.0%
Days Payable 168192175168 -4.0%
Cash Conversion Cycle -59-93-77-71 +7.8%
Working Capital Days 26-37-70-41 +41.4%
ROCE % 7%7%7%6% -14.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 62.46%63.78%63.77%64.21%64.21% +0.0%
FIIs 2.16%3.59%3.22%2.76%2.69% -2.5%
DIIs 13.22%18.36%18.30%18.91%20.77% +9.8%
Public 22.17%14.28%14.71%14.15%12.32% -12.9%
No. of Shareholders 47,02846,97045,36647,64944,774 -6.0%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Healthcare Global Enterprises Limited's revenue in Q1 FY27?
Healthcare Global Enterprises Limited reported revenue of ₹377 crore for the quarter ended June 2026 (Q1 FY27), up 15.2% from ₹327 crore in the same quarter last year, and up 7.6% sequentially over the March 2026 quarter.
What was Healthcare Global Enterprises Limited's net profit in Q1 FY27?
Net profit rose 61.7% year-on-year to ₹6 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹0.37.
What is HCG's market capitalisation and P/E ratio?
At the current price of ₹588.20, HCG has a market capitalisation of ₹8,782 crore and a P/E that is not meaningful, because trailing profit is close to zero.
Who owns Healthcare Global Enterprises Limited? (shareholding pattern)
As of Sep 2026, promoters held 64.21%, foreign institutional investors (FIIs) 2.69%, domestic institutional investors (DIIs) 20.77%, public shareholders 12.32% of Healthcare Global Enterprises Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI